/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122950-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC Iron Sucrose 100 mg Weekly Ver 11-20-17 (HL 1858)

CSC SC Iron Sucrose 100 mg Weekly Ver 11-20-17 (HL 1858) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC IRON SUCROSE 100 MG WEEKLY VER: 11-20-17 –  Properties
Cycle 1 –  11/21/2017 through 12/18/2017 (28 days), Planned
Day 1, Cycle 1 –  Planned for 11/21/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 8, Cycle 1 –  Planned for 11/28/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 15, Cycle 1 –  Planned for 12/5/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:35:17 AM Page 1 of 5
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 22, Cycle 1 –  Planned for 12/12/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Cycle 2 –  12/19/2017 through 1/15/2018 (28 days), Planned
Day 1, Cycle 2 –  Planned for 12/19/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 8, Cycle 2 –  Planned for 12/26/2017
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:35:17 AM Page 2 of 5
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 15, Cycle 2 –  Planned for 1/2/2018
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 22, Cycle 2 –  Planned for 1/9/2018
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Cycle 3 –  1/16/2018 through 2/12/2018 (28 days), Planned
Day 1, Cycle 3 –  Planned for 1/16/2018
Treatment Conditions
Treatment Condition A
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:35:17 AM Page 3 of 5
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 8, Cycle 3 –  Planned for 1/23/2018
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 15, Cycle 3 –  Planned for 1/30/2018
Treatment Conditions
Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Day 22, Cycle 3 –  Planned for 2/6/2018
Treatment Conditions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:35:17 AM Page 4 of 5
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org

Treatment Condition A
Clinical guidelines for administration:
Desired critical lab values for holding or administering iron sucrose:
***
Hydration
sodium chloride 0.9 % infusion
at 20 mL/hr, Intravenous, ONCE, 1 dose Starting when released
To establish line and for flushing
Supportive Care Medications
iron sucrose (VENOFER) 20 MG/ML injection 100 mg
100 mg, Intravenous, ONCE, 1 dose Starting when released
Refer to IV Administration Guidelines for infusion duration based upon ordered dose.
Actions
Actions
Actions
Actions
Actions
Zztestonc,Fiona F [2462287]
11/21/2017 10:35:17 AM Page 5 of 5
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org